Reference 2019-28

REF:           2019-28

Subject:       Ophthalmology injections and implants

 

Request:

Within your Trust how many Intra-vltreat Injections / Implants have been used in the latest 4 months, if possible between September and December ’18.

If your Trust is able to identify Injections / Implants by eye conditions please split by the drug used (Ranibizumab, Bevacizumab, Aflibercept, Fluocinolone and Dexamethasone)

 

 

Response:

Injections / implants

Total

Lucentis (Ranibizumab) Injections

871

Avastin (Bevacizumab) Injections

3

Eylea (Aflibercept) Injections

1098

Illuvieb (Fluocinolone) Implants

0

Ozudex (Dexamethasone) Implants

9

Please note that we are unable to provide figures for individual eye conditions (Wet Age Related Macular Degeneration (wAMD); Diabetic Macular Oedema (DMO); Retinal Vein Occlusion – Central or Branch (CRVO or BRVO); Other e.g. mCNV) only totals.

Visitor restrictions

To protect you and our staff during the current outbreak of Covid-19 we’ve put in place significant restrictions on hospital visitors.

Full details of these can be found on our website.

We would like to thank you for your understanding and helping us stop the spread of Covid-19.

Read More

Stay Home. Protect the NHS. Save Lives.

Close